Plain-English translation of NCT06593951 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a research study designed to understand how progressive myoclonus epilepsy type 1 (a rare genetic seizure disorder) changes over time in different patients. Instead of requiring you to travel to a hospital, the study uses video calls and remote assessments to track your health from home. Researchers will collect information about your symptoms, do some blood tests, and ask questions about how the disease affects your daily life—all to help prepare for future treatments.
Progressive myoclonus epilepsy type 1 is extremely rare, which means doctors don't have enough information about how it progresses in different patients or what changes to look for when testing new treatments. By gathering detailed information from patients spread across the country, researchers can better understand the disease and get ready to test new therapies that might help.
You likely qualify if…
You likely don't qualify if…
You will participate in remote assessments conducted through video calls, which means you can join from home. The study will collect information about your symptoms and disease history, ask you to complete questionnaires about your quality of life, and may request blood samples to create a research biobank. The study aims to track how your condition evolves over time to help doctors understand the disease better and prepare for future clinical trials.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
United States